WhatsApp에서 다음 내용을 보냅니다
대화 계속하기According to the NCI website Alpelisib is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Alpelisib specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, thereby inhibiting the activation of the PI3K signaling pathway. … https://oncoletter.ch/krebstherapie/alle-wirkstoffe/wirkstoff/alpelisib-piqray-r.html